Piper Sandler Downgrades Ncino to Neutral, Lowers Price Target to $22
Piper Sandler analyst Brent Bracelin downgrades Ncino (NASDAQ:NCNO) from Overweight to Neutral and lowers the price target from $30 to $22.
Tesla Shares Downgraded On ‘Macro Challenges’: How The Collapse Of SVB Financial Could Impact EV Leader
An analyst is downgrading shares of electric vehicle leader Tesla Inc (NASDAQ: TSLA), and the fallout from the collapse of several banks is one reason why.
Raymond James Downgrades First Republic Bank, Outlines Risks In ‘Uncertain Environment’
Raymond James analyst David Long released a note on First Republic Bank (NYSE: FRC), downgrading his rating from a Strong Buy to Market Perform, but did not change his price target of $150 a share.
Evercore ISI Group Downgrades Seagen to In-Line, Raises Price Target to $229
Evercore ISI Group analyst Joshua Schimmer downgrades Seagen (NASDAQ:SGEN) from Outperform to In-Line and raises the price target from $175 to $229.
Craig-Hallum Downgrades Edgio to Hold, Lowers Price Target to $1
Craig-Hallum analyst Jeff Van Rhee downgrades Edgio (NASDAQ:EGIO) from Buy to Hold and lowers the price target from $2.5 to $1.
Wells Fargo Downgrades Signature Bank
Wells Fargo analyst Steven Chercover downgrades Signature Bank (NASDAQ:SBNY)
Odeon Capital Downgrades KeyCorp to Hold
Odeon Capital analyst Dick Bove downgrades KeyCorp (NYSE:KEY) from Buy to Hold.
Credit Suisse Downgrades Diversey Hldgs to Neutral, Lowers Price Target to $8.4
Credit Suisse analyst John Roberts downgrades Diversey Hldgs (NASDAQ:DSEY) from Outperform to Neutral and lowers the price target from $9 to $8.4.
Citigroup Downgrades Petco Health and Wellness to Neutral, Announces $11 Price Target
Citigroup analyst Steven Zaccone downgrades Petco Health and Wellness (NASDAQ:WOOF) from Buy to Neutral and announces $11 price target.
Bernstein Downgrades Lam Research to Market Perform
Bernstein analyst Stacy Rasgon downgrades Lam Research (NASDAQ:LRCX) from Outperform to Market Perform.